Omega Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2024 to a ratio of 3.83, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2024. Average receivable collection period, for the Omega Therapeutics Inc in Sep 30 2024 quarter, has decreased to 95 days, compared to 121 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 560 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 3019 to 3716.

What is Receivable Turnover Ratio?
What is Omega Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OMGA Receivables Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Receivable Change	22.42 %	-42.38 %	141.89 %	892.07 %	-36.88 %
Y / Y Revenue Change	214.32 %	181.16 %	357.36 %	34.6 %	39.66 %
Receivable Turnover Ratio (TTM)	3.83	3.02	2.22	1.51	4.22
OMGA's Total Ranking	# 3716	# 3019	# 3419	# 3497	# 3007
Accounts Receivable average collection period days	95	121	164	242	86
Seq. Receivable Change	-29.77 %	-39.77 %	-81.26 %	1444.33 %	-66.94 %
Seq. Revenue Change	22.4 %	-9.58 %	138.87 %	18.89 %	9.49 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 58
Healthcare Sector	# 561
Overall Market	# 3716

Receivable Turnover Ratio Statistics
High	Average	Low
0.05	0.02	0.01
(Sep 30 2024)		(Dec 31 2022)

OMGA Company Profile • Back to OMGA Efficiency Comparisons • Compare OMGA Receivables Turnover Ratio to its Competitors

Financial Statements
Omega Therapeutics Inc 's Accounts Receivable	$ 0 Millions	Visit OMGA's Balance sheet
Omega Therapeutics Inc 's Sales TTM	$ 8 Millions	Visit OMGA's Income Statement
Sources of OMGA's Revenues		Visit OMGA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OMGA's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OMGA's Growth Rates	OMGA's Roa	OMGA's Inventory Turnover Ratio	OMGA's Dividend Comparisons
OMGA's Profitability Ratios	OMGA's Roi	OMGA's Asset Turnover Ratio	OMGA's Dividend Growth
OMGA's Valuation Ratios	OMGA's Roe	OMGA's Financial Strength Ratios	OMGA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
Cervomed Inc	44.74	$ 13.194 Millions	$ 0.295 Millions
Nature s Sunshine Products inc	43.22	$ 445.255 Millions	$ 10.302 Millions
Agape Atp Corporation	43.15	$ 1.354 Millions	$ 0.031 Millions
Electrocore Inc	39.37	$ 22.458 Millions	$ 0.571 Millions
Fonar Corporation	36.37	$ 102.006 Millions	$ 2.804 Millions
Lifemd Inc	34.47	$ 192.420 Millions	$ 5.583 Millions
Ontrak Inc	34.00	$ 10.336 Millions	$ 0.304 Millions
Vivos Therapeutics Inc	33.86	$ 13.340 Millions	$ 0.394 Millions
Xoma Royalty Corporation	33.52	$ 21.606 Millions	$ 0.645 Millions
23andme Holding Co	33.34	$ 191.889 Millions	$ 5.756 Millions
Eyepoint Inc	32.81	$ 45.713 Millions	$ 1.393 Millions
Clearside Biomedical Inc	32.16	$ 7.703 Millions	$ 0.240 Millions
Spero Therapeutics Inc	30.43	$ 106.456 Millions	$ 3.498 Millions
Invo Fertility Inc	29.95	$ 6.228 Millions	$ 0.208 Millions
Cv Sciences Inc	29.75	$ 14.867 Millions	$ 0.500 Millions
Orchestra Biomed Holdings Inc	29.33	$ 2.647 Millions	$ 0.090 Millions
National Vision Holdings Inc	29.03	$ 1,952.174 Millions	$ 67.248 Millions
Sonida Senior Living Inc	27.68	$ 278.115 Millions	$ 10.046 Millions
Renalytix Plc	27.67	$ 2.352 Millions	$ 0.085 Millions
Neuraxis Inc	27.03	$ 2.456 Millions	$ 0.091 Millions
Marpai Inc	26.21	$ 30.093 Millions	$ 1.148 Millions
Adaptimmune Therapeutics Plc	25.59	$ 175.041 Millions	$ 6.841 Millions
Recursion Pharmaceuticals Inc	24.89	$ 65.184 Millions	$ 2.619 Millions
Lineage Cell Therapeutics Inc	23.85	$ 8.719 Millions	$ 0.366 Millions
Agenus Inc	23.56	$ 160.428 Millions	$ 6.810 Millions
Kymera Therapeutics Inc	23.35	$ 87.563 Millions	$ 3.750 Millions
Editas Medicine Inc	22.87	$ 61.758 Millions	$ 2.701 Millions
U S Physical Therapy Inc	22.39	$ 645.699 Millions	$ 28.841 Millions
Bespoke Extracts Inc	22.31	$ 1.080 Millions	$ 0.048 Millions
Cytomx Therapeutics Inc	22.28	$ 126.617 Millions	$ 5.684 Millions

Date modified: 2026-08-29T17:44:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.